During the last FHU-impact (https://www.chu-toulouse.fr/-federation-hospitalo-universitaire-impact-) meeting held on December 2, 2022,  Stanislas Faguer is presenting the latest work from Alexis Piedrafita on the identification and large scale validation of urinary peptides. We believe that such urinary signatures will help in the future to personalise medicine in the development of acute kidney injury. This work is now also published in the high impact journal Critical Care: https://ccforum.biomedcentral.com/articles/10.1186/s13054-022-04193-9